https://validator.w3.org/feed/docs/rss2.html Home Page 7. How do I prepare for a 6 month follow up interview? 8. What if the participant has died before their 6 month follow up? REVIVe Research Program 7. If a patient is repatriated to a non-REVIVe hospital, do we enroll them? 5. Do we enroll a patient who has met the inclusion criteria and have survived the ICU but has been identified as palliative or focus on comfort measures when they are transferred to the ward? Meet the Team REVIVe Consent Process Help FAQs 7. I have a patient who was admitted to ICU with Sepsis cause by an acute respiratory infection. Should they be included? 4. Is the 6-month follow-up from hospital discharge or P/ICU discharge? 4. Patient does not have a fixed address, does not live in Canada, or the RC believes it may be difficult to contact them for follow-up; do we still enroll? Training Resources 5. How can I determine whether a patient has a suspected acute respiratory infection? 4. What is high flow oxygen? 8. If a patient is bedridden at baseline, would they still be eligible for REVIVe? 6. If a patient is admitted to ICU for another reason say a brain bleed, and while they are in ICU they develop a HAP. If it is within the first 14 days of ICU admission are they eligible? Research Coordinator Resources Updates 1. Patient is on the ward with an ARI and receiving 40% high flow nasal cannula. Is this patient eligible based on the new criteria? Newsletter 2. Patient is admitted to P/ICU with GI bleed as the main admitting diagnosis, but has a secondary diagnosis of pneumonia. Is this patient eligible? 6. What is the window for collecting the 6-month follow-up assessment? 5. My patient is due for their 6-month follow-up assessment. They were just re-admitted to hospital and this acute illness has resulted in a major change in their function and health status. Should I collect the assessment based on their current status or on how they were doing prior to re-admission? 3. Patient is admitted to the medical ward with RSV (respiratory syncytial virus). Patient deteriorates on day 5 post-hospital admission, is transferred to P/ICU, and requires invasive ventilation. Is the patient eligible? 6. What studies are approved for co-enrollment? 3. Despite earlier predictions of survival, a consented REVIVe patient has died during their P/ICU stay. How is this data handled? 6. When is Study day 1? 5. What if rehabilitation interventions were performed by someone other than the listed therapists? 4. What does the “Yes (no note documented, treatment provided)” column in the daily data CRF mean? 3. On the daily data, do we select ICU or ward if a patient was transferred to the ward that day? 2. How many days do we need to collect daily data for? 2. When is module 3a (Outcomes-Extubation) completed? 1. What is considered a failed extubation attempt (Module 3a)? 1. If a patient was admitted to the ICU, discharged, then re-admitted, but only tested positive for COVID-19 during the second admission, which ICU admission date do we record on Module 1? 2. Are we only including patients admitted DUE to COVID-19? What about those diagnosed during their hospital stay? 1. Are we collecting data for patients who survived their P/ICU stay but did not survive their hospital stay? 3. If a patient is transferred to another acute care centre, can they be enrolled in REVIVe? 2. How long will the 6-month follow-up phone calls take? 1. Can the follow-up assessment be performed by the SDM? Contact 1. Does daily data collection only include P/ICU?